Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongli Li

Showing results (491-500 of 639) with videos related to

Pageof 64
Sort By:
Journal of Translational Medicine|April 24, 2023
Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacologyYuqing Liu, Hongli Li, Xiaowei Wang, et al.
Archives of Physical Medicine and Rehabilitation|August 16, 2020
Comparative Effect of Liuzijue Qigong and Conventional Respiratory Training on Trunk Control Ability and Respiratory Muscle Function in Patients at an Early Recovery Stage From Stroke: A Randomized Controlled TrialYanan Zheng, Ying Zhang, Hongli Li, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcomeShijun Lu, Na Niu, Hua Guo, et al.
Haematologica|July 3, 2025
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trialAlexey V Danilov, Hongli Li, Mazyar Shadman, et al.
ACS Applied Materials & Interfaces|October 27, 2023
Double-Layer Hydrogel with Glucose-Activated Two-Stage ROS Regulating Properties for Programmed Diabetic Wound HealingMin Tan, Jing Zeng, Fu-Zhong Zhang, et al.
Investigational New Drugs|January 6, 2025
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancerRui Liu, Zhi Ji, Xia Wang, et al.
Cell Death & Disease|December 14, 2020
Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular spongeHongli Li, Qingjie Mu, Guoxin Zhang, et al.
Therapeutic Advances in Chronic Disease|September 18, 2023
Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world studyTing Deng, Jingjing Duan, Ming Bai, et al.
The Science of the Total Environment|February 11, 2018
Polycyclic aromatic hydrocarbons (PAHs) associated with PM<sub>2.5</sub> within boundary layer: Cloud/fog and regional transportMinmin Yang, Yan Wang, Hongli Li, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Pageof 64

Showing results (491-500 of 639) with videos related to

Sort By:
Pageof 64
Journal of Translational Medicine|April 24, 2023
Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacologyYuqing Liu, Hongli Li, Xiaowei Wang, et al.
Archives of Physical Medicine and Rehabilitation|August 16, 2020
Comparative Effect of Liuzijue Qigong and Conventional Respiratory Training on Trunk Control Ability and Respiratory Muscle Function in Patients at an Early Recovery Stage From Stroke: A Randomized Controlled TrialYanan Zheng, Ying Zhang, Hongli Li, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcomeShijun Lu, Na Niu, Hua Guo, et al.
Haematologica|July 3, 2025
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trialAlexey V Danilov, Hongli Li, Mazyar Shadman, et al.
ACS Applied Materials & Interfaces|October 27, 2023
Double-Layer Hydrogel with Glucose-Activated Two-Stage ROS Regulating Properties for Programmed Diabetic Wound HealingMin Tan, Jing Zeng, Fu-Zhong Zhang, et al.
Investigational New Drugs|January 6, 2025
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancerRui Liu, Zhi Ji, Xia Wang, et al.
Cell Death & Disease|December 14, 2020
Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular spongeHongli Li, Qingjie Mu, Guoxin Zhang, et al.
Therapeutic Advances in Chronic Disease|September 18, 2023
Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world studyTing Deng, Jingjing Duan, Ming Bai, et al.
The Science of the Total Environment|February 11, 2018
Polycyclic aromatic hydrocarbons (PAHs) associated with PM<sub>2.5</sub> within boundary layer: Cloud/fog and regional transportMinmin Yang, Yan Wang, Hongli Li, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Pageof 64